Reddy-Sitagliptin and Metformin Hydrochloride 850 mg

REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 850 MG tablets combine two active ingredients for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 850 MG tablets are commonly used to help manage type 2 diabetes. This combination medication works by improving insulin sensitivity and reducing glucose production in the liver. It is often prescribed for individuals who require additional glycemic control beyond diet and exercise alone. The primary use of this medication is to support blood sugar management in adults with type 2 diabetes.

Common effects of REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 850 MG tablets may include gastrointestinal discomfort, such as nausea, diarrhea, or abdominal pain. Some individuals may also experience headache or dizziness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 850 MG tablets should be handled with care, especially for individuals with kidney or liver issues. It is important to follow the prescribed dosage and administration instructions. Regular monitoring of blood sugar levels is recommended. Always consult a healthcare provider before starting or stopping any medication.

REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 850 MG tablets may interact with certain medications, including other diabetes treatments, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.